Anti-inhibitor coagulant complex Intravenous and Factor VIIa (Recombinant)
Determining the interaction of Anti-inhibitor coagulant complex Intravenous and Factor VIIa (Recombinant) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Ask your doctor before using anti-inhibitor coagulant complex together with coagulation factor VIIa. Using these medications together may increase your risk of developing a blood clot. Call your doctor promptly if you have any signs of blood clots such as chest pain, shortness of breath, sudden loss of vision, or pain, redness or swelling in an extremity. You may need a dose adjustment in addition to testing of your prothrombin time or International Normalized Ratio (INR). It is important that you tell your healthcare provider about all other medications that you are using including vitamins and herbs. Do not stop using your medications without talking to your doctor first.
Professional:GENERALLY AVOID: The risk of a potential interaction between coagulation factor VIIa and coagulation factor concentrates has not been adequately evaluated in preclinical or clinical studies. Theoretically, patients receiving concomitant therapy may have an increased risk of developing thrombotic events.
MANAGEMENT: Product labeling for coagulation factor VIIa recommends that simultaneous use of activated or nonactivated prothrombin complex concentrates be avoided.
- "Product Information. NovoSeven (coagulation factor VIIa)" Novo Nordisk Pharmaceuticals, Princeton, NJ.
Generic Name: anti-inhibitor coagulant complex
Brand name: Feiba, Feiba VH Immuno, Autoplex T, Feiba NF
Synonyms: Anti-inhibitor coagulant complex, Anti-inhibitor Coagulant Complex (Human)
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anti-inhibitor coagulant complex Intravenous-Factor X (Human)
- Anti-inhibitor coagulant complex Intravenous-Factor x human Intravenous
- Anti-inhibitor coagulant complex Intravenous-Factor XIII
- Anti-inhibitor coagulant complex Intravenous-Factor XIII (Human)
- Anti-inhibitor coagulant complex Intravenous-Factor XIII A-Subunit (Recombinant)
- Anti-inhibitor coagulant complex Intravenous-Factor XIII Concentrate (Human)
- Factor VIIa (Recombinant)-Anti-Itch (Diphenhydramine (Topical))
- Factor VIIa (Recombinant)-Anti-Itch Maximum Strength
- Factor VIIa (Recombinant)-Anti-thymocyte globulin rabbit
- Factor VIIa (Recombinant)-Antibiotic Cream Topical
- Factor VIIa (Recombinant)-Antibiotic Otic
- Factor VIIa (Recombinant)-Antibiotic Plus Pain Relief